[1] Chen W,Zheng R,Zhang S,et al. Annual report on status of cancer in China,2010[J].Chin J Cancer Res,2014,26(1):48-58. [2] 孙朝文,周崇民,张皓,等.晚期结肠癌患者生物治疗临床应用的研究进展[J].重庆医学,2017,46(8):1123-1125. [3] LeCouter J,Kowalski J,Foster J,et al.Identification of an angiogenic mitogen selective for endocrine gland endothelium[J].Nature,2001,412(6850):877-884. [4] Goi T,Nakazawa T,Hirono Y,et al.Prokineticin 1 expression in gastrointestinal tumors[J].Anticancer Res,2013,33(12):5311-5315. [5] Corlan AS,Cmpean AM,Jitariu AA,et al.Endocrine gland-derived vascular endothelial growth factor/prokineticin-1 in cancer development and tumor angiogenesis.[J].Internat J Endocrinol,2017,2017(4):3232905. [6] Ngan ES,Tam PK.Prokineticin-signaling pathway[J].Int J Biochem Cell Biol,2008,40(9):1679-1684. [7] 董延琥,栾文强,李兴坤,等.PROK1在结肠癌组织中的表达及其与转移的相关性[J].中国实用医药,2016,11(22):16-18. [8] Goi T,Nakazawa T,Hirono Y,et al.The prognosis was poorer in colorectal cancers that expressed both VEGF and PROK1(No correlation coefficient between VEGF and PROK1)[J].Oncotarget,2015,6(30):28790-28799. [9] Bai LM,Huang XF,Xu HM.Investigation of microvessel density and related factors expression for xenografts tumor of HT-29 cells in nude mice at different growth stages[J].Chin Pharmacol Bull,2014,30(6):796-800. [10] 李西霞,王晓春.EZH2通过抑制miR-608基因表达促进结肠癌细胞增殖[J].基因组学与应用生物学,2016,35(4):745-751. [11] Nakazawa T,Goi T,Hirono Y,et al.Prokineticin 1 protein expression is a useful new prognostic factor for human sporadic colorectal cancer[J].Ann Surg Oncol,2015,22(5):1496-1503. [12] Traboulsi W,Bouffetal H,Aboussaouira T,et al.EG-VEGF and its receptors are deregulated in complete hydatiform moles:Potential role in placental tumor development[J].Placenta,2014,35(9):A50. [13] Morales A,Morimoto S,Vilchis F,et al.Molecular expression of vascular endothelial growth factor,prokineticin receptor-1 and other biomarkers in infiltrating canalicular carcinoma of the breast.[J].Oncol Lett,2016,12(4):2720. [14] Ren L,Guo X,Shao X,et al.Endocrine gland-derived vascular endothelial growth factor modulates proliferation,apoptosis and migration in pancreatic cancer cells[J].Mol Med Rep,2015,11(6):4279-4284. [15] Goi T,Nakazawa T,Hirono Y,et al.The anti-tumor effect is enhanced by simultaneously targeting VEGF and PROK1 in colorectal cancer[J].Oncotarget,2015,6(8):6053-6061. [16] Goi T,Nakazawa T,Hirono Y,et al.Anti-prokineticin1 (PROK1) monoclonal antibody suppresses angiogenesis and tumor growth in colorectal cancer[J].Ann Surg Oncol,2014,21 (Suppl 4):S665. [17] 史剑飞,邓红玉,冯赫宇,等.靶向干扰PROK1基因对结直肠癌细胞HT29增殖和迁移的影响[J].基因组学与应用生物学,2017,36(4):1294-1300. [18] Su MT,Tsai PY,Tsai HL,et al.miR-346 and miR-582-3p-regulated EG-VEGF expression and trophoblast invasion via matrix metalloproteinases 2 and 9[J].Biofactors,2017,43(2):210-219. [19] Akanori G,Hidetaka K,Yuki U,et al.Expression of prokineticin-receptor2(PK-R2) is a new prognostic factor in human colorectal cancer:[J].Oncotarget,2015,6(31):31758-31766. [20] 闻崇炜,周夕莲,刘瑞江.EG-VEGF在肿瘤治疗中的应用前景[J].中国医药导报,2010,7(1):173. [21] 张玲,屈亚威,谈涛,等.高分辨率显微内镜对结肠癌诊断价值的初步研究[J].解放军医学杂志,2016,41(9):746-748. |